Transcat (NASDAQ: TRNS) is one of 24 publicly-traded companies in the “Electronic Component” industry, but how does it weigh in compared to its rivals? We will compare Transcat to related businesses based on the strength of its profitability, risk, valuation, analyst recommendations, earnings, institutional ownership and dividends.
Volatility & Risk
Transcat has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500. Comparatively, Transcat’s rivals have a beta of 1.01, indicating that their average share price is 1% more volatile than the S&P 500.
This table compares Transcat and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Transcat||$143.90 million||$4.52 million||23.16|
|Transcat Competitors||$1.21 billion||$129.73 million||108.62|
Transcat’s rivals have higher revenue and earnings than Transcat. Transcat is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Insider and Institutional Ownership
57.1% of Transcat shares are held by institutional investors. Comparatively, 56.7% of shares of all “Electronic Component” companies are held by institutional investors. 8.8% of Transcat shares are held by company insiders. Comparatively, 9.0% of shares of all “Electronic Component” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares Transcat and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current recommendations for Transcat and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Transcat currently has a consensus target price of $20.00, suggesting a potential upside of 26.98%. As a group, “Electronic Component” companies have a potential downside of 1.46%. Given Transcat’s stronger consensus rating and higher possible upside, equities analysts clearly believe Transcat is more favorable than its rivals.
Transcat beats its rivals on 7 of the 13 factors compared.
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.